This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXNPEB6J0AJ_M.jpg
Orbimed Capital’s holding in Prelude Therapeutics Incorporat established a new holding of about 917 thousand shares with the purchase.
Orbimed Capital established new holdings in Prelude Therapeutics Incorporat
4 years ago
No Comments
Related Posts
Renewable diesel boom highlights challenges in clean-energy transition
March 3, 2021
Airbus investing up to 1 billion euros on A220 passenger jet program this year
February 20, 2020
Exclusive-Twitter to introduce new controls for ad placements -email
December 9, 2022
Hong Kong transport operators, supermarkets cut services as COVID cases surge
March 3, 2022
U.S. Treasury to pay down $26 billion in debt in Q2
May 2, 2022
U.S. Stock Index Futures Fall as Mideast Tensions Hurt Sentiment
January 5, 2020
About The Author
